Sweeping changes to childhood vaccine guidance in the United States mean that several vaccines, including those for COVID-19, influenza and RSV, are no longer universally recommended.
A McGill University expert is available to comment:
Jesse Papenburg, MD, is an Associate Professor in the Department of Pediatrics, infectious disease specialist at the Montreal Children’s Hospital and Chair of the Quebec Immunization Committee.
Dr. Timothy Evans, Inaugural Director and Associate Dean at the School of Population and Global Health and Executive Director of Canada's COVID-19 Immunity Task Force Secretariat is among the experts quoted by the Toronto Star.
"More Canadians may soon be offered a fourth dose of the COVID-19 vaccine, but the extent of the protection it provides remains to be seen.
McGill University has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. McGill is the first university in Canada to join this program as it ramps up its international rollout.
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is among the experts quoted by Global News.
Dr. Madhukar Pai, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and past McGill Global Health Programs Director, is among the experts interviewed by CBC The Current.
Dr. Joanne Liu, Professor focusing on pandemic and health emergencies at the McGill School of Population and Global Health (SPGH) is one of two experts quoted by Radio-Canada.
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is among the experts quoted by the Montreal Gazette.
Dr. Joanne Liu, Professor focusing on pandemic and health emergencies at the McGill School of Population and Global Health (SPGH) authored an op-ed in La Presse.
"Pendant que nous nous réjouissons du taux de vaccination que nous avons atteint au Canada, la pandémie continue de faire rage dans d’autres parties du monde. Les images crève-cœur qui nous parviennent nous montrent des patients au souffle court se battant contre la COVID-19."
Dr. Timothy Evans, Inaugural Director and Associate Dean at the School of Population and Global Health and Executive Director of Canada's COVID-19 Immunity Task Force Secretariat is among the experts quoted by the Montreal Gazette.
"As Quebec’s COVID-19 vaccination campaign picks up speed, with more than 30 per cent of Quebec adults having received at least one shot, many wonder when all these jabs and safety measures will start to turn the tide."
Dr. Timothy Evans, Inaugural Director and Associate Dean at the School of Population and Global Health and Executive Director of Canada's COVID-19 Immunity Task Force Secretariat is among the experts quoted in this piece.
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force discusses prospects for achieving mass immunization.
"Vaccination frenzy grips Canada. This week saw several major developments in Canada's COVID-19 vaccine rollout. Health Canada approved a fourth vaccine, while provinces moved quickly to extend the window in which a second dose can be administered."
Dr. Jay Kaufman, of the Department of Epidemiology, Biostatistics and Occupational Health, is quoted in this Globe and Mail piece on the likeliness of the United States sharing vaccines with Canada.
Read the article (subscription may be required)
McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker, that provides real-time updates on progress in developing a safe and effective vaccine.
